🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Emmanuele Andreano Emanuele Andreano from ToscanaLifeSciences for being chosen as an IUIS Rising Star to be honored at #IUIS2023. This prestigious award is given to 15 of the most promising early investigators. Learn more at iuis2023.org.

It is a great honor to receive this prestigious award by International Union of Immunological Societies. Looking forward to share with the community our work on monoclonal antibodies to tackle emerging infectious diseases. ToscanaLifeSciences #MADLab #mAbs

Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens biorxiv.org/cgi/content/sh… #biorxiv_immuno

#AMR is a silent pandemic and new tools are needed to treat and prevent bacterial infection. In our latest work, we have identified human monoclonal antibodies able to kill Gonococcus, a bacterium resistant to almost all class of antibiotics. Check it out: biorxiv.org/content/10.110…

Another example of #SARSCoV2 infected cells forming syncytia. Label-free holotomography and AI-based image analysis #Nanolive microscope biorxiv.org/content/10.110

We are standing on the cusp of a new era of biology, where the integration of multimodal structural datasets with multiscale physics-based simulation will enable the development of visible, virtual cells. My dream for #COVIDisAirborne Kimberly Prather, Ph.D. & the molecular basis of life

... and this 'impossible review' on the future of cell & molecular biology marks the Amaro Lab's 200th paper 🍾🤓💜 So grateful & proud of this wonderful group, all members, past & present, helping make these impossible (nerd) dreams come true! 🥰❤️

B cell maturation restored ancestral germlines to control Omicron BA.2.86 biorxiv.org/cgi/content/sh… #biorxiv_immuno

B cell maturation restored ancestral germlines to control Omicron BA.2.86 | bioRxiv fantastic collaboration with Monoclonal Antibody Discovery (MAD) lab, ⁦ToscanaLifeSciences⁩ Siena, Italy 🇮🇹 biorxiv.org/content/10.110…

SARS-CoV-2 JN.1 variant L455S sequence abolishes the neutralizing antibody response of the publicly shared IGHV3-53/3-66, contributing to its global spread Science Immunology Emanuele Andreano Rappuoli science.org/doi/10.1126/sc…

We interrogated our panel of almost 900 neutralizing human monoclonal antibodies to understand how JN.1 was able to evade the antibody response and become the main SARS-CoV-2 variant worldwide. Check the full paper out published in Science Immunology: science.org/doi/10.1126/sc…

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses dlvr.it/TCTcqz

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses sciencedirect.com/science/articl…

Our new work on monoclonal antibodies to fight #gonorrhea just got out on Science Translational Medicine! We are unleashing the full power of antibodies to accelerate vaccine development and new solutions to #AMR Check the full paper out 👇 science.org/doi/abs/10.112…